News
While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...
Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...
Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...
7h
ZME Science on MSNOzempic Works Wonders Until You Stop. Then, the Weight Starts to Come BackThat’s how long it takes, on average, for the pounds to begin creeping back after someone stops taking the world’s most ...
GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little evidence of improving cardiorespiratory fitness, researchers say.
CLEVELAND - A new study published by Cleveland Clinic researchers investigating the genetic underpinnings of weight loss response has identified a ...
More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor agonists offer neuroprotective and cerebrovascular benefits beyond what can ...
Everyone aspires to live a healthy life. The catch is that health is a moving target. It’s a challenge that changes as people ...
Healthcare professionals are calling for a fundamental shift in public perception around medically supervised weight loss ...
A new study published by Cleveland Clinic researchers in Diabetes, Obesity and Metabolism investigating the genetic ...
Older age and female sex may be associated with greater muscle loss in adults with obesity prescribed semaglutide.
Tirzepatide outperformed semaglutide in simultaneously achieving four key therapeutic targets for type 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results